Works matching DE "GLUCAGON-like peptide 1"

Results: 3083

Cardiovascular-kidney-metabolic syndrome medications: A time to rebrand?

Published in:

American Journal of Health-System Pharmacy, 2025, v. 82, n. 12, p. 738, doi. 10.1093/ajhp/zxaf042

By:

Maxson, Rebecca;
Neumiller, Joshua J;
Aistrope, Dan;
Weltman, Melanie R;
Chow, Sheryl

Publication type:

Article

Now and the Future: Medications Changing the Landscape of Cardiovascular Disease and Heart Failure Management.

Published in:

Journal of Clinical Medicine, 2025, v. 14, n. 11, p. 3948, doi. 10.3390/jcm14113948

By:

Oswald, Thomas;
Coombs, Steven;
Ellery, Susan;
Liu, Alexander

Publication type:

Article

The Premise of the Paradox: Examining the Evidence That Motivated GIPR Agonist and Antagonist Drug Development Programs.

Published in:

Journal of Clinical Medicine, 2025, v. 14, n. 11, p. 3812, doi. 10.3390/jcm14113812

By:

Douros, Jonathan D.;
Mowery, Stephanie A.;
Knerr, Patrick J.

Publication type:

Article

Glucagon-Like Peptide-1 and Hypothalamic Regulation of Satiation: Cognitive and Neural Insights from Human and Animal Studies.

Published in:

Diabetes & Metabolism Journal, 2025, v. 49, n. 3, p. 333, doi. 10.4093/dmj.2025.0106

By:

Joon Seok Park;
Kyu Sik Kim;
Hyung Jin Choi

Publication type:

Article

Mechanism-guided drug development and treatment for liver fibrosis: a clinical perspective.

Published in:

Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2025.1574385

By:

Zeng, Xiangchang;
Huang, Deliang;
Zhu, Zhibin;
Cai, Qingxian;
Yang, Yang;
Lu, Hongzhou;
Chen, Jun

Publication type:

Article

Trends in antidiabetic drug use in Portugal: 8 years real‐world data from a nationwide retrospective observational study (2017–2024) (TREND‐8 study).

Published in:

Diabetes, Obesity & Metabolism, 2025, v. 27, n. 7, p. 4022, doi. 10.1111/dom.16429

By:

Neves, João Sérgio;
Leite, Ana Rita;
Marcelino, Mafalda;
Melo, Miguel;
Freitas, Paula;
Ramalho, Célia;
Calçada, Eduardo

Publication type:

Article

Case Report: Amelioration of severe metabolic dysfunction-associated steatohepatitis after switching from conventional GLP-1RAs to tirzepatide.

Published in:

2025

By:

Oe, Yuki;
Omori, Takashi;
Aimono, Eriko;
Furukawa, Shin;
Kitakawa, Hirohiko;
Tateno, Masatoshi;
Sakai, Kiyoshi;
Cho, Kyu Yong

Publication type:

Case Study

Higher Compliance with Treatment Administration Instructions for Injectable Dulaglutide versus Oral Semaglutide Reported by People with Type 2 Diabetes in Clinical Practice Settings in Spain: The TRU-Experience Study.

Published in:

Patient Preference & Adherence, 2025, v. 19, p. 1231, doi. 10.2147/PPA.S509483

By:

Díaz-Cerezo, Silvia;
Artime, Esther;
Redondo-Antón, Jennifer;
Duque, Natalia;
Spaepen, Erik;
Cruz, Miguel Ángel Mangas;
Arnas-Leon, Claudia;
Olveira, Gabriel;
Rodríguez, Irene Rodríguez;
Alagarda, María Teresa Julián;
Valdés, Nuria;
Merchante, Agustín Ángel;
Masmiquel, Lluís;
Santos, Miriam Rubio-de

Publication type:

Article

Revisiting the markers interleukin-6 and glucagon-like peptide-1 for targeting low-grade inflammation in type 2 diabetes: a meta-analysis and our lab experience.

Published in:

Acta Diabetologica, 2025, v. 62, n. 6, p. 811, doi. 10.1007/s00592-024-02398-8

By:

Bara, Jyoti Kiran;
Gandhi, Puneet;
Verma, Pramod

Publication type:

Article

Cross-talk between microbiota-gut-brain axis and blood pressure regulation.

Published in:

Clinical Science, 2025, v. 139, n. 9, p. 431, doi. 10.1042/CS20240787

By:

Welathanthree, Malindi;
Keating, Damien J.;
Macefield, Vaughan G.;
Carnevale, Daniela;
Marques, Francine Z.;
Muralitharan, Rikeish R.

Publication type:

Article

Editorial: Nervous system and reproduction: a highly integrative partnership.

Published in:

Frontiers in Endocrinology, 2025, p. 1, doi. 10.3389/fendo.2025.1621411

By:

Lara, Hernan E.;
Dorfman, Mauricio D.;
Mayerhofer, Artur

Publication type:

Article

Management of Acquired Hypothalamic Obesity After Childhood-Onset Craniopharyngioma—A Narrative Review.

Published in:

Biomedicines, 2025, v. 13, n. 5, p. 1016, doi. 10.3390/biomedicines13051016

By:

Müller, Hermann L.

Publication type:

Article

Comparative effectiveness of semaglutide versus liraglutide, dulaglutide or tirzepatide: a systematic review and meta-analysis.

Published in:

Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2025.1438318

By:

Karimi, Mohammad Amin;
Gholami Chahkand, Mohammad Sadra;
Dadkhah, Parisa Alsadat;
Sheikhzadeh, Farzad;
Yaghoubi, Shayan;
Esmaeilpour Moallem, Fatemeh;
Deyhimi, Mitra Sadat;
Arab Bafrani, Melika;
Shahrokhi, Mehregan;
Nasrollahizadeh, Amir

Publication type:

Article

A Novel Camel Milk-Derived Peptide LLPK Improves Glucose-Lipid Metabolism in db / db Mice via PPAR Signaling Pathway.

Published in:

Nutrients, 2025, v. 17, n. 10, p. 1693, doi. 10.3390/nu17101693

By:

Han, Binsong;
Ye, Yuhui;
Zhang, Cunzheng;
Zhang, Lina;
Zhou, Peng

Publication type:

Article

Update on Emergency Department Sedation.

Published in:: Emergency Medicine Reports, 2025, v. 46, n. 11, p. 1
Publication type:: Article

Beneficial effects of liraglutide on peripheral blood vessels.

Published in:

Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journal of Serbia, 2022, v. 79, n. 2, p. 168, doi. 10.2298/VSP200423089Z

By:

Xueyang Zhang;
Yongbo Wang;
Simengge Yang;
Junwei Zong;
Xuejiao Wang;
Ran Bai

Publication type:

Article

Short term effects of experimental gastric outlet obstruction and truncal vagotomy on gut hormones.

Published in:

Biotechnic & Histochemistry, 2022, v. 97, n. 2, p. 90, doi. 10.1080/10520295.2021.1896780

By:

Sagkan Ozturk, Aliye;
Aydin, Mehmet;
Bozkurt, Yesim Akaydın;
Kuçukgul, Altug;
Ozturk, Atakan

Publication type:

Article

Diabetes and disordered bone metabolism (diabetic osteodystrophy): time for recognition.

Published in:

Osteoporosis International, 2016, v. 27, n. 6, p. 1931, doi. 10.1007/s00198-015-3454-x

By:

Epstein, S.;
Defeudis, G.;
Manfrini, S.;
Napoli, N.;
Pozzilli, P.

Publication type:

Article

Double incretin receptor knock-out (DIRKO) mice present with alterations of trabecular and cortical micromorphology and bone strength.

Published in:

Osteoporosis International, 2015, v. 26, n. 1, p. 209, doi. 10.1007/s00198-014-2845-8

By:

Mieczkowska, A.;
Mansur, S.;
Bouvard, B.;
Flatt, P.;
Thorens, B.;
Irwin, N.;
Chappard, D.;
Mabilleau, G.

Publication type:

Article

The role of anti-diabetic drugs in NAFLD. Have we found the Holy Grail? A narrative review.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 1, p. 127, doi. 10.1007/s00228-023-03586-1

By:

Zachou, Maria;
Flevari, Pagona;
Nasiri-Ansari, Narjes;
Varytimiadis, Constantinos;
Kalaitzakis, Evangelos;
Kassi, Eva;
Androutsakos, Theodoros

Publication type:

Article

Association between glucagon-like peptide-1 receptor gene polymorphism and treatment response to GLP1R agonists in Chinese patients with type 2 diabetes: a prospective cohort study.

Published in:

European Journal of Clinical Pharmacology, 2022, v. 78, n. 5, p. 793, doi. 10.1007/s00228-021-03249-z

By:

Guan, Ziwan;
Du, Yue;
Li, Rui;
Zhang, Shufang;
Xu, Yuedong;
Zhang, Xiaoqian;
Zhang, Fan;
Yin, Ying;
Wu, Kunrong;
Li, Xiaoli;
Li, Yan

Publication type:

Article

Exendin-4 improves cerebral ischemia by relaxing microvessels, rapidly increasing cerebral blood flow after reperfusion.

Published in:

Basic Research in Cardiology, 2025, v. 120, n. 2, p. 423, doi. 10.1007/s00395-025-01096-y

By:

Chen, Yujie;
Wang, Lei;
Zhou, Yutong;
Wang, Yuguang;
Qin, Wei;
Wang, Mingxiao;
Liu, Bo;
Tian, Qian;
Xu, Huisen;
Shen, Hui;
Zheng, Chen

Publication type:

Article

Exendin-4 attenuates adverse cardiac remodelling in streptozocin-induced diabetes via specific actions on infiltrating macrophages.

Published in:

Basic Research in Cardiology, 2016, v. 111, n. 1, p. 1, doi. 10.1007/s00395-015-0518-1

By:

Tate, Mitchel;
Robinson, Emma;
Green, Brian;
McDermott, Barbara;
Grieve, David

Publication type:

Article

Glucagon-like peptide-1 (7-36) but not (9-36) augments cardiac output during myocardial ischemia via a Frank-Starling mechanism.

Published in:

Basic Research in Cardiology, 2014, v. 109, n. 5, p. 1, doi. 10.1007/s00395-014-0426-9

By:

Goodwill, Adam;
Tune, Johnathan;
Noblet, Jillian;
Conteh, Abass;
Sassoon, Daniel;
Casalini, Eli;
Mather, Kieren

Publication type:

Article

Impaired cardiometabolic responses to glucagon-like peptide 1 in obesity and type 2 diabetes mellitus.

Published in:

Basic Research in Cardiology, 2013, v. 108, n. 4, p. 1, doi. 10.1007/s00395-013-0365-x

By:

Moberly, Steven;
Mather, Kieren;
Berwick, Zachary;
Owen, Meredith;
Goodwill, Adam;
Casalini, Eli;
Hutchins, Gary;
Green, Mark;
Ng, Yen;
Considine, Robert;
Perry, Kevin;
Chisholm, Robin;
Tune, Johnathan

Publication type:

Article

Evaluation of Serum Glucagon-Like Peptide 1 and Vitamin D Levels in Elderly Patients with Bone Fractures.

Published in:

2020

By:

Pazarci, Özhan;
Dogan, Halef Okan;
Kilinc, Seyran;
Çamurcu, Yalkin;
Dogan, Halef Okan

Publication type:

journal article

Molecular Pharmacology of the Incretin Receptors.

Published in:

2016

By:

Al-Sabah, Suleiman

Publication type:

journal article

Effect of Different Types of Hypoglycemic Medications on Psoriasis: An Analysis of Current Evidence.

Published in:

Dermatology (10188665), 2023, v. 239, n. 2, p. 299, doi. 10.1159/000528026

By:

Sun, Xiaoying;
Cai, Xiaoce;
Liu, Liu;
Li, Hongjin;
Zhou, Yaqiong;
Luo, Ying;
Su, Yonghua;
Li, Bin;
Li, Xin

Publication type:

Article

Viking Therapeutics Completes Enrollment for Phase 2 Trial of Oral Obesity Tablet.

Published in:

Patient Care (Online), 2025, p. N.PAG

By:

Halsey, Grace

Publication type:

Article

Semaglutide 7.2 mg Achieves Weight Reduction of 21% in Late-Stage STEP UP Trial.

Published in:

Patient Care (Online), 2025, p. 1

By:

Halsey, Grace

Publication type:

Article

Viking Therapeutics Launches Phase 2 Trial for Oral VK2735 in Patients with Obesity.

Published in:

Patient Care (Online), 2025, p. 3

By:

Jennings, Sydney

Publication type:

Article

Investigational Maridebart Cafraglutide Shows Promise for Obesity, T2D: Daily Dose.

Published in:

2024

By:

Jennings, Sydney

Publication type:

Abstract

Antiobesity Medications May Help Lower Alcohol Use, New Study Suggests.

Published in:

2024

By:

Jennings, Sydney

Publication type:

Abstract

Amgen Reports Promising Phase 2 Data on MariTide for Obesity, Type 2 Diabetes Management.

Published in:

Patient Care (Online), 2024, p. 3

By:

Jennings, Sydney

Publication type:

Article

New Phase 3 Trials Investigate Survodutide as a Promising Treatment for Obesity.

Published in:

2024

By:

Jennings, Sydney

Publication type:

Abstract

ObesityWeek 2024: Viking Therapeutics Presents New Positive Data from VK2735 Obesity Program: Results from the VENTURE phase 2 trial and a phase I oral formulation study found that VK2735, a dual GLP-1 and GIP receptor agonist, demonstrated promise in treating obesity

Published in:

Patient Care (Online), 2024, p. 1

By:

Jennings, Sydney

Publication type:

Article

GLP-1RAs Reduce the Risk of Early-Onset Colorectal Cancer in Adults with T2D.

Published in:

Patient Care (Online), 2024, p. 4

By:

Jennings, Sydney

Publication type:

Article

GLP-1RAs Reduce Suicide Risk in Youth with Obesity: Daily Dose.

Published in:

Patient Care (Online), 2024, p. 1

By:

Jennings, Sydney

Publication type:

Article

Exclusive Physician Survey Results on GLP-1 Receptor Agonists: The Hype Is Real.

Published in:: Patient Care (Online), 2024, p. 1
Publication type:: Article

Novel GLP-1 RA for Obesity Shows Promise in Early Phase 1 Trial.

Published in:

Patient Care (Online), 2024, p. 1

By:

Halsey, Grace

Publication type:

Article

Tirzepatide Tied to Lower Risk for Death, Adverse CV and Kidney Outcomes vs GLP-1s: Daily Dose.

Published in:

Patient Care (Online), 2024, p. 1

By:

Jennings, Sydney

Publication type:

Article

GLP-1RAs, SGLT-2 Inhibitors Tied to Lower Adverse Cardiovascular and Liver Events in Persons with T2D, MASLD.

Published in:

Patient Care (Online), 2024, p. 3

By:

Jennings, Sydney

Publication type:

Article

New Online Tracker May Help Patients Find GLP-1RA Medication More Easily.

Published in:

Patient Care (Online), 2024, p. 1

By:

Jennings, Sydney

Publication type:

Article

Semaglutide Explored for Treatment of Alcohol, Nicotine Use Disorders.

Published in:

Patient Care (Online), 2024, p. 1

By:

O'Brien, Erin

Publication type:

Article

Real-World Studies Show Significant HbA1c Reductions with GLP-1 RA and Freestyle Libre CGM Used Together.

Published in:

Patient Care (Online), 2024, p. 1

By:

Halsey, Grace

Publication type:

Article

Viking Therapeutics Dual GIP/GLP-1 Mimetic Drives Weight Loss of Up to 14.7% in Phase 2 Findings.

Published in:

Patient Care (Online), 2024, p. 1

By:

Halsey, Grace

Publication type:

Article

Effect of Glucagon-like Peptide-1 on the Differentiation of Adipose-derived Stem Cells into Osteoblasts and Adipocytes.

Published in:

Journal of Menopausal Medicine, 2020, v. 26, n. 2, p. 93, doi. 10.6118/jmm.2015.21.2.93

By:

Hye Min Lee;
Bo Sun Joo;
Chang Hoon Lee;
Heung Yeol Kim;
Ji Hoon Ock;
Young Seok Lee

Publication type:

Article

Effect of Glucagon-like Peptide-1 on the Differentiation of Adipose-derived Stem Cells into Osteoblasts and Adipocytes.

Published in:

Journal of Menopausal Medicine, 2015, v. 21, n. 2, p. 93, doi. 10.6118/jmm.2015.21.2.93

By:

Hye Min Lee;
Bo Sun Joo;
Chang Hoon Lee;
Heung Yeol Kim;
Ji Hoon Ock;
Young Seok Lee

Publication type:

Article

Renoprotective Effects of Mineralocorticoid Receptor Antagonists Against Diabetic Kidney Disease.

Published in:

Advanced Biology, 2024, v. 8, n. 3, p. 1, doi. 10.1002/adbi.202300496

By:

Bayne, Sarah;
LeFevre, James;
Olstinske, Kayla;
Ravindran, Sreenithya;
Munusamy, Shankar

Publication type:

Article

Evaluation of Glucagon-Like Peptide 1 (GLP-1) Levels and Oxidative Stress in Preterm Infants.

Published in:

Caspian Journal of Pediatrics, 2022, v. 24, n. 1, p. 18, doi. 10.22088/jbums.24.1.18

By:

Abbasi, E.;
Pishbin, F.;
Shahsavar, N. Tahmasebpour;
Shahabi, R.;
Ghafari, M. E.;
Tabatabai, S.;
Heidari, S.

Publication type:

Article